Subscribe to RSS - Rick Glass

Rick Glass

Buckle up, 2018 is going to be ‘huge’ for M&A, analysts say


YARMOUTH, Maine – Expect to see large regional HME players get bigger in the year ahead as they look to increase their market share, say M&A analysts.

Uncertainty kills Teijin’s bid for US HME market

But Teijin’s loss may be PE firm’s gain

YARMOUTH, Maine – Teijin Limited’s recent announcement that it was exiting the U.S. homecare market is a textbook example of the cooling off of a once red-hot market, say industry analysts.

M&A: Buyer appetite for HME improves


YARMOUTH, Maine – After a slow first quarter, buyer appetites for HME businesses are picking up, say M&A analysts.

Coloplast deal signals larger trend


MINNEAPOLIS – Coloplast’s willingness to pay an eye-popping $160 million for Comfort Medical points to the attractiveness of the disposable medical supplies market, say analysts.

M&A: Are supplies a sleeper category?


When Liberty Medical drew 33 bidders to a sale of its assets in November, no one was more surprised than industry analysts.

Rotech ready to expand


ORLANDO, Fla. – Rotech Healthcare last week announced its first acquisition in several years and the company has indicated that’s only the beginning.

Merger casts ‘positive’ light on industry


ORLANDO – News of a merger between AeroCare and MergeWorthRx put a spring into the step of HME industry analysts.

“This a positive sign for the industry,” said Rick Glass, president of Steven Richards & Associates. 

Audit uncertainty drags on deals


YARMOUTH, Maine – It was a slow first quarter for mergers and acquisitions, say industry analysts.

It’s still a buyer’s market, analysts say

A look at the year that was and the year that is

YARMOUTH, Maine – Competitive bidding drove acquisition activity in 2013 and analysts say it will power decisions in the year ahead.

Apria ready for new ‘world,’ analysts say


LAKE FOREST, Calif. – Apria Healthcare has repositioned itself as a respiratory-focused company with the sale of its home infusion business, Coram, to CVS Caremark, say analysts.